Tenax Therapeutics (TENX) Share-based Compensation: 2010-2017
Historic Share-based Compensation for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to $64.
- Tenax Therapeutics' Share-based Compensation fell 68.63% to $64 in Q4 2017 from the same period last year, while for Dec 2017 it was $79,793, marking a year-over-year increase of 7413.47%. This contributed to the annual value of $1.1 million for FY2024, which is 489.01% up from last year.
- As of Q4 2017, Tenax Therapeutics' Share-based Compensation stood at $64, which was down 4.48% from $67 recorded in Q2 2017.
- Tenax Therapeutics' 5-year Share-based Compensation high stood at $1.4 million for Q1 2014, and its period low was $64 during Q4 2017.
- In the last 3 years, Tenax Therapeutics' Share-based Compensation had a median value of $276.50 in 2015 and averaged $14,851.
- Per our database at Business Quant, Tenax Therapeutics' Share-based Compensation crashed by 98.23% in 2015 and then soared by 25,285.94% in 2017.
- Over the past 5 years, Tenax Therapeutics' Share-based Compensation (Quarterly) stood at $1.3 million in 2013, then slumped by 97.24% to $34,868 in 2014, then plummeted by 98.19% to $268 in 2015, then reached $204 in 2016, then tumbled by 68.63% to $64 in 2017.
- Its last three reported values are $64 in Q4 2017, $67 for Q2 2017, and $79,458 during Q1 2017.